Literature DB >> 31497221

HSF1: a mediator in metabolic alteration of hepatocellular carcinoma cells in cross-talking with tumor-associated macrophages.

Hua Tian Liu1,2, Dan Ai Huang3, Miao Miao Li1, He Deng Liu3, Kun Guo1.   

Abstract

Recently, heat shock transcription factor 1 (HSF1) is observed to be involved in the process of cellular metabolism in cancer. However, the roles of HSF1 in the metabolic alteration of hepatocellular carcinoma (HCC) in tumor microenvironment remain elusive. Here, HCC cells were co-cultured with tumor-associated macrophages (TAM). The levels of glucose uptake, the lactate release, reactive oxygen species (ROS) and mtDNA content were measured by the associated Kits; all detected protocols were correspondingly according to the manufacturers' instructions. Recombinant lentiviruses with shRNA against HSF1 and MCT4 were transfected into HCC cells or TAMs. Western blot analysis was conducted to detect the relative levels of HSF1, MCT1 and MCT4 proteins. CCK-8 assay was utilized to assess cell proliferation. Based on the co-culture system with HCC cells and TAMs, metabolic alteration of HCC cells after co-culture with TAMs was observed. Furthermore, glucose consumption rate, lactate production rate and intercellular ROS level were decreased, while the copy number of mtDNA was increased in HSF1-knockdown HCC cells. Besides, metabolic crosstalk between HCC cells and TAMs was induced by HSF1 not only in HCC cells but also in TAMs through regulating individually MCT1 and MCT4 expressions. To the best of our knowledge, this is an important study to demonstrate the roles of HSF1 in regulating metabolic alteration of HCC cells induced by TAMs, which implies the potential use of HSF1 as a target modulating malignant behaviors of HCC cells.

Entities:  

Keywords:  Hepatocellular carcinoma; heat shock transcription factor 1; metabolic phenotype; tumor-associated macrophages

Year:  2019        PMID: 31497221      PMCID: PMC6731433     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  39 in total

1.  Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome.

Authors:  Xiongjie Jin; Demetrius Moskophidis; Nahid F Mivechi
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

2.  Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect.

Authors:  David A Scott; Adam D Richardson; Fabian V Filipp; Christine A Knutzen; Gary G Chiang; Ze'ev A Ronai; Andrei L Osterman; Jeffrey W Smith
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

Review 3.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

4.  The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.

Authors:  Stephanos Pavlides; Diana Whitaker-Menezes; Remedios Castello-Cros; Neal Flomenberg; Agnieszka K Witkiewicz; Philippe G Frank; Mathew C Casimiro; Chenguang Wang; Paolo Fortina; Sankar Addya; Richard G Pestell; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2009-12-05       Impact factor: 4.534

5.  Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1.

Authors:  Sandy D Westerheide; Julius Anckar; Stanley M Stevens; Lea Sistonen; Richard I Morimoto
Journal:  Science       Date:  2009-02-20       Impact factor: 47.728

Review 6.  Inhibiting the transcription factor HSF1 as an anticancer strategy.

Authors:  Luke Whitesell; Susan Lindquist
Journal:  Expert Opin Ther Targets       Date:  2009-04       Impact factor: 6.902

Review 7.  Emerging metabolic targets in cancer therapy.

Authors:  Yuhua Zhao; Hao Liu; Adam I Riker; Oystein Fodstad; Susan P Ledoux; Glenn L Wilson; Ming Tan
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

8.  Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.

Authors:  Richard Possemato; Kevin M Marks; Yoav D Shaul; Michael E Pacold; Dohoon Kim; Kıvanç Birsoy; Shalini Sethumadhavan; Hin-Koon Woo; Hyun G Jang; Abhishek K Jha; Walter W Chen; Francesca G Barrett; Nicolas Stransky; Zhi-Yang Tsun; Glenn S Cowley; Jordi Barretina; Nada Y Kalaany; Peggy P Hsu; Kathleen Ottina; Albert M Chan; Bingbing Yuan; Levi A Garraway; David E Root; Mari Mino-Kenudson; Elena F Brachtel; Edward M Driggers; David M Sabatini
Journal:  Nature       Date:  2011-08-18       Impact factor: 49.962

9.  IDH2 mutations in patients with D-2-hydroxyglutaric aciduria.

Authors:  Martijn Kranendijk; Eduard A Struys; Emile van Schaftingen; K Michael Gibson; Warsha A Kanhai; Marjo S van der Knaap; Jeanne Amiel; Neil R Buist; Anibh M Das; Johannis B de Klerk; Annette S Feigenbaum; Dorothy K Grange; Floris C Hofstede; Elisabeth Holme; Edwin P Kirk; Stanley H Korman; Eva Morava; Andrew Morris; Jan Smeitink; Rám N Sukhai; Hilary Vallance; Cornelis Jakobs; Gajja S Salomons
Journal:  Science       Date:  2010-09-16       Impact factor: 63.714

10.  Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.

Authors:  Chengkai Dai; Luke Whitesell; Arlin B Rogers; Susan Lindquist
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

View more
  2 in total

Review 1.  Lactate: The Mediator of Metabolism and Immunosuppression.

Authors:  Yuanyuan Zhang; Zhao Zhai; Jiali Duan; Xiangcai Wang; Jinghua Zhong; Longqiu Wu; An Li; Miao Cao; Yanyang Wu; Huaqiu Shi; Jianing Zhong; Zhenli Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

2.  Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma.

Authors:  Miaomiao Li; Juntao Hu; Riming Jin; Hongxia Cheng; Huaping Chen; Limin Li; Kun Guo
Journal:  J Hepatocell Carcinoma       Date:  2020-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.